ADIAL PHARMACEUTICALS, INC. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Adial Pharmaceuticals, Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2021 to Q1 2023.
  • Adial Pharmaceuticals, Inc. Deferred Income Tax Liabilities, Net for the quarter ending March 31, 2023 was $22.9K, a 2.15% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $22.9K -$502 -2.15% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $1.69K -$21.7K -92.8% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 $23.4K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $23.4K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $23.4K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $23.4K Dec 31, 2021 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.